I am framing my strategy with a low risk tolerance though. So when I say I am accumulating, I still see this company very much as a speccie and won't allocate more than 2-3% of total portfolio. If/when it makes it into the ASX 300 I will re-adjust from there - assuming all things are looking good.
We all have different risk tolerances but I think it should be kept in mind, as we have just seen late last year, the company also has risks that could impact dramatically and it certainly wont be clear sailing from here to 2x SP growth (as much as that is a crazy notion for some posters here )
Nova Eye Medical (EYE) Discussion, page-1958
-
- There are more pages in this discussion • 1,230 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $48.87K | 198.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 385197 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 14358 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |